The Search for Nothing
In December 1979, an international commission of experts met in Geneva with a strange assignment: it had to confirm the disappearance of smallpox in nature. The disease had killed 300 million people during the 20th century alone, and its final known trail led to Somalia in 1977. The commission had two years of worldwide searching behind it, along with reports gathered by national health systems and field teams.
Its members faced a standard of proof far higher than a final patient. Smallpox passed from person to person, so a hidden infection in a remote community could keep the virus alive. Teams had to find active cases, trace the people around them, and establish that every reported suspicion had reached an answer. Geneva would celebrate only after that search could account for the silence.
How did Henderson’s tiny international programme end smallpox across divided countries?
A Proposal Crosses Borders
Dr. Victor Zhdanov brought the idea to Minneapolis in May 1958, where he led the Soviet delegation at the eleventh World Health Assembly. His resolution urged member states to begin a five-year worldwide smallpox eradication programme. A majority approved it, giving the World Health Organization a mandate built around a disease that moved freely between national borders.
The vote followed years of discussion. Dr. Brock Chisholm, then WHO director-general, had proposed a worldwide campaign in 1953, and member states had asked regional offices, governments and expert groups to study the matter together. The 1958 resolution gave WHO headquarters in Geneva a specific job: work with its regional offices to bring national governments into a common effort.
That instruction described a chain of institutions, yet the chain had to carry practical supplies. Between 1959 and 1966, the Soviet Union alone donated more than 400 million doses of vaccine. The United States, Sweden and other Asian and European countries contributed field operatives, vaccine, operating kits and money.
The campaign could draw resources from countries with very different interests because every country had reason to fear an infection arriving from elsewhere.
The First Programme Moves Slowly
WHO launched the Smallpox Eradication Programme in 1959, drawing on a vaccine whose history stretched back to Edward Jenner’s work in 1796. Jenner had inoculated eight-year-old James Phipps with matter from a cowpox sore in May of that year, then tested Phipps’s resistance with matter from a human smallpox sore in July. Phipps remained in perfect health, and extensive testing had shown the vaccine’s protective effect by 1801.
By the 1950s, vaccine production had solved another part of the problem. Heat-stable, freeze-dried vaccine could be stored without refrigeration, making it far more useful in places far from reliable cold storage. Leslie Collier’s method produced a potent heat-stable vaccine that could travel around the world, giving field workers a tool suited to the campaign’s vast geography. The programme’s structures still grew slowly through 1967, shaped by international negotiations and voluntary support.
Smallpox continued to expose the cost of that slow progress. It could kill at least one in three people infected, often more in severe forms, and in 1967 endemic countries existed in four of WHO’s six regions.
Vaccine alone could not tell a team where infection was moving.
A Ten-Year Demand
The World Health Assembly made that demand on 10 May 1966, when it decided to undertake an intensified programme to eradicate smallpox from the face of the earth within 10 years. The plan was to begin on 1 January 1967, with hopes that the final case would be discovered and isolated by 31 December 1976. No disease had previously been eradicated.
Dr. Marcelino Candau, WHO’s director-general, saw the scale of the task clearly. Candau, a Brazilian, expressed absolute certainty that eradication in the Amazon basin was impossible. His view rested on the conditions that defined the work: vast distances, uneven health systems, high costs, competing strategies and places where reaching a village itself could take a team on foot.
Delegates had attached the 10-year limit to John F. Kennedy’s statement that “we will land a man on the moon in 10 years.” If that ambition could send a person to the moon, they reasoned, a coordinated effort could eliminate smallpox on Earth.
The intensified programme began in January 1967 with more than 10 million cases and 2 million deaths in 43 countries. Its budget had first been set at $2.5 million for programmes in 50 countries, while its intended reach extended to more than 1 billion people.
Henderson’s Small Unit
D. A. Henderson arrived in Geneva on 26 October 1966 to become chief of the Smallpox Eradication Unit. He was 38 and had ten years of public-health experience. The campaign he took on would eventually include people from 73 nationalities, while the international field staff never exceeded 150 people.
Those numbers made national programmes the campaign’s working body. Henderson fought in 1966 for stronger interlinked national chapters, which could carry surveillance, vaccination and rapid local responses into communities where cases appeared. WHO headquarters could coordinate experience and resources, while the decisive work depended on health workers who knew the territories, languages and institutions around them.
Its staff could bring experience from one country into another, support national teams and press for faster reporting, yet a few international workers could never conduct a worldwide search themselves. Henderson’s approach placed the campaign inside national health work, where workers could hear of a rash, investigate a report and act on it before the next chain of transmission took hold.
India showed why that arrangement mattered. The country had more than 20 major languages along with several local dialects, and it had long drawn international attention as a major reservoir of smallpox. Jawaharlal Nehru, India’s prime minister, regarded widespread variola as a stigma for his government’s agenda, yet senior officials across federal and state health ministries were deeply divided over eradication.
The country had already invested heavily in reaching people through mass vaccination.
A Vaccine in the Bag
Field teams had a tool designed for work far from headquarters. Health workers could carry freeze-dried vaccine in their bags for 30 days and still find it potent. The programme also began experimenting with the bifurcated needle in 1967, giving workers a practical way to vaccinate people as they moved through demanding terrain.
A scientist at Wyeth Laboratory had invented it, and the small instrument gave workers a means to deliver vaccine while travelling between communities. Teams still faced the larger challenge of transport: remote villages could be difficult to reach, and workers often went on foot.
India had already committed time and resources to mass vaccination, and its results forced a sharper argument. Smallpox persisted after the country reached 80% vaccination coverage. An expert committee answered with a recommendation for 100% coverage, which expressed the ambition of the existing approach while teams faced outbreaks moving through densely populated communities.
Mahendra Dutta, a physician and public-health leader, helped usher in a different strategy across India. Search and containment sent workers to track active cases, isolate infected people and vaccinate anyone the patient might have contacted. Mass vaccination had proved ineffective in densely populated regions where containment proved more effective, concentrating workers on the live routes of transmission.
India Finds Its Argument
Dutta’s strategy changed what counted as the essential work. Vaccination remained central, and the work began with a search: workers had to learn that a person was ill, reach that person, identify contacts and act before infection reached another household or community. Surveillance became the system that directed vaccine toward the disease’s remaining paths.
That sequence gave individual reports great weight. Each report could lead workers to an infected person, and each infected person could lead workers to the people exposed around them. Containment made the campaign responsive to the disease’s movement through actual households and communities. The task demanded quick information as much as it demanded a reliable supply of vaccine.
The method also sharpened disagreements between agencies. Unpublished correspondence shows that bodies sponsored by WHO and the Indian government were often at loggerheads over strategy, even as Henderson later described national and WHO staff working “shoulder to shoulder” with “technical competence, dedication and enthusiasm.”
A 1970 outbreak in south-west India made the stakes plain. It led to more than 1,300 cases and 123 deaths. Each case gave search-and-containment teams a starting point, and each missed connection left room for the virus to continue. India’s experience supplied the practical method that the global programme would carry into its final years.
Khan Meets a Harder Question
Shahidul Haq Khan travelled from community to community in southern Bangladesh, where smallpox eradication unfolded amid natural disaster, civil war, sectarian violence and famine. People asked him, “There’s no rice in people’s stomachs, so what is a vaccine going to do?” The question placed a campaign against immediate hunger and made every visit an argument for preventive action.
Khan had to make the campaign intelligible under conditions where food was the urgent concern. His answer lay in the work itself: finding infection early, separating an infected person from further contacts and protecting those contacts before the virus moved again. The strategy offered communities a way to stop a disease that brought its own suffering into an already unstable setting.
Khan’s work required the same close attention that India’s strategy demanded. A team had to hear of an active case, reach the community, isolate the infected person and vaccinate close contacts. Workers faced difficult transport to remote villages and often travelled on foot. The programme’s small international staff could support the effort, while local workers carried it into the lives of people facing far more pressing demands.
Smallpox gave those workers a narrow period in which to interrupt transmission. An infected person could spread the virus for three to four weeks while rash and scabs were present. The virus also had no animal reservoir: it needed a human host to survive. Each successful containment therefore removed one link from a chain that had persisted for at least 3,000 years.
The Last Known Link
Ali Maow Maalin was 23 and worked as a cook in Somalia when he developed smallpox. He became the last recorded case of variola minor. The final documented naturally occurring case was diagnosed in Merka, Somalia, in 1977, giving eradication teams a final known point from which to search outward through every possible connection.
Maalin’s illness came after another marker of the campaign’s progress. Rahima Banu, a three-year-old on Bhola Island in Bangladesh, had recovered from variola major in 1975 as its last recorded case. Maalin’s variola minor case then placed the final human link in Somalia. Recovery closed one known chain, while the programme still had to establish that no unseen chain survived elsewhere.
That search continued for two years. It depended on surveillance systems built through national programmes, reports investigated by field workers and the biological fact that smallpox could survive only by infecting people. Smallpox had been eliminated from South America in 1971, Asia in 1975 and Africa in 1977. Somalia’s final case left the commission in Geneva with the hardest question of all: whether the quiet that followed represented a true end.
The programme had cost about US$300 million between 1967 and 1980, with two thirds borne by endemic countries. It had enlisted thousands of health workers to administer half a billion vaccinations, joined to the detective work of search and containment. The annual savings since eradication have exceeded US$1 billion, yet Geneva’s decision rested on the search for a person who might still carry the virus.
Geneva Gives the Answer
The global commission delivered its verdict on 9 December 1979: smallpox had been eradicated. Henderson’s unit had remained small because it was built to connect national workers. Soviet vaccine donations, durable doses in workers’ bags, local reporting and a strategy that followed every case had made the commission’s confidence possible.
Candau’s Amazon objection had captured the campaign’s hardest practical problem, while Dutta’s strategy gave teams a way to follow transmission through dense communities. Khan carried that method into places where hunger and upheaval shaped every conversation, and Maalin’s recovery began the final search.
The World Health Assembly gathered in May 1980 to turn certification into a formal declaration. Its success came through people finding transmission wherever it still appeared, then closing the circle around it.
On 8 May 1980, the 33rd World Health Assembly declared: “The world and all its peoples have won freedom from smallpox.”
Comments (0)